Mechanistic insight from murine models of Netherton syndrome

References

Bitoun, E., Chavanas, S., Irvine, A.D., Lonie, L., Bodemer, C., Paradisi, M., Hamel-Teillac, D., Ansai, S., Mitsuhashi, Y., Taïeb, A., et al. (2002). Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J. Invest. Dermatol. 2, 352–361.10.1046/j.1523-1747.2002.01603.xSuche in Google Scholar PubMed

Bonnart, C., Deraison, C., Lacroix, M., Uchida, Y., Besson, C. Robin, A., Briot, A., Gonthier, M., Lamant, L., Dubus, P., et al. (2010). Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. J. Clin. Invest. 120, 871–882.10.1172/JCI41440Suche in Google Scholar PubMed PubMed Central

Borgoño, C.A., Michael, I.P., Komatsu, N., Jayakumar, A., Kapadia, R., Clayman, G.L., Sotiropoulou, G., and Diamandis, E.P. (2007). A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J. Biol. Chem. 282, 3640–3652.10.1074/jbc.M607567200Suche in Google Scholar PubMed

Brattsand, M., Stefansson, K., Lundh, C., Haasum, Y., and Egelrud, T. (2005). A proteolytic cascade of kallikreins in the stratum corneum. J. Invest Dermatol. 124, 198–203.10.1111/j.0022-202X.2004.23547.xSuche in Google Scholar PubMed

Briot, A., Deraison C., Lacroix M., Bonnart C., Robin A., Besson C., Dubus P., and Hovnanian, A. (2009). Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton Syndrome. J. Exp. Med. 206, 1135–1147.10.1084/jem.20082242Suche in Google Scholar PubMed PubMed Central

Caubet, C., Jonca, N., Brattsand, M., Guerrin, M., Bernard, D., Schmidt, R., Egelrud, T., Simon, M., and Serre, G. (2004). Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J. Invest. Dermatol. 122, 1235–1244.10.1111/j.0022-202X.2004.22512.xSuche in Google Scholar PubMed

Chavanas, S., Bodemer, C., Rochat, A., Hamel-Teillac, D., Ali, M., Irvine, A.D., Bonafé, J.L., Wilkinson, J., Taïeb, A., Barrandon, Y., Harper, J.I., de Prost, Y. and Hovnanian, A. (2000). Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet. 2, 141–142.10.1038/75977Suche in Google Scholar PubMed

Comel, M. (1949). Ichtyosis Linearis circumflexa. Dermatologica 98, 133–136.10.1159/000257290Suche in Google Scholar

De Veer, S., Furio, L., Harris, J.M., and Hovnanian, A. (2014). Proteases: common culprits in human skin disorders. Trends Mol. Med. 20, 166–178.10.1016/j.molmed.2013.11.005Suche in Google Scholar PubMed

Deraison, C., Bonnart, B., Lopez, F., Besson, C., Robinson, R., Jayakumar, A., Wagberg, F., Brattsand, M., Hachem, J.P., Leonardsson, G., et al. (2007). LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol. Biol. Cell 9, 3607–3619.10.1091/mbc.e07-02-0124Suche in Google Scholar PubMed PubMed Central

Descargues, P., Deraison, C., Bonnart, C., Kreft, M., Kishibe, M., Ishida-Yamamoto, A., Elias, P., Barrandon, Y., Zambruno, G., Sonnenberg, A., et al. (2005). Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat. Genet. 37, 56–65.10.1038/ng1493Suche in Google Scholar PubMed

Descargues, P., Deraison, C., Prost, C., Fraitag, S., Mazereeuw-Hautier, J., D’Alessio, M., Ishida-Yamamoto, A., Bodemer, C., Zambruno, G., and Hovnanian, A. (2006). Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin and chymotrypsinlike hyperactivity in Netherton syndrome. J. Invest. Dermatol. 126, 1622–1632.10.1038/sj.jid.5700284Suche in Google Scholar PubMed

Egelrud, T., Brattsand, M., Kreutzmann, P., Walden, M., Vitzithum, K., Marx, U.C., Forssman, W.G., and Magert, H.J. (2005). hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. Br. J. Dermatol. 153, 1200–1203.10.1111/j.1365-2133.2005.06834.xSuche in Google Scholar PubMed

Fartasch, M., Williams, M.L., and Elias, P.M. (1999). Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome. Arch. Dermatol. 135, 823–832.10.1001/archderm.135.7.823Suche in Google Scholar PubMed

Frateschi, S., Camerer, E., Crisante, G., Rieser, S., Membrez, M., Charles, R.P., Beermann, F., Stehle, J.C., Breiden, B., Sandhoff, K., et al. (2011). PAR2 absence completely rescues inflammation and ichthyosis caused by altered CAP1/Prss8 expression in mouse skin. Nat. Commun. 2, 161.10.1038/ncomms1162Suche in Google Scholar PubMed PubMed Central

Furio, L., de Veer, S., Jaillet, M., Briot, A., Robin, A., Deraison, C., and Hovnanian, A. (2014). Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome. J. Exp. Med. 211, 499–513.10.1084/jem.20131797Suche in Google Scholar PubMed PubMed Central

Furio, L., Pampalakis, G., Iacovos, P., Michael, Nagy, A., Sotiropoulou, G., and Hovnanian, A. (2015). KLK5 inactivation reverses cutaneous hallmarks of Netherton syndrome. PLoS Genet. 11, 1–20.10.1371/journal.pgen.1005389Suche in Google Scholar PubMed PubMed Central

Hausser, I. and Anton-Lamprecht, I. (1996). Severe congenital generalized exfoliative erythroderma in newborns and infants: a possible sign of Netherton syndrome. Pediatr. Dermatol. 13, 183–199.10.1111/j.1525-1470.1996.tb01202.xSuche in Google Scholar PubMed

Judge, M.R., Morgan, G., and Harper, J.I. (1994). A clinical and immunological study of Netherton’s syndrome. Br. J. Dermatol. 131, 615–621.10.1111/j.1365-2133.1994.tb04971.xSuche in Google Scholar PubMed

Leclerc-Mercier, S., Bodemer, C., Furio, L., Hadj-Rabia, S., de Peufeilhoux, L., Weibel, L., Bursztejn, A.C., Bourrat, E., Ortonne, N., Molina, T.J., et al. (2016). Am. J. Dermatopathol. 38, 83–91.10.1097/DAD.0000000000000425Suche in Google Scholar PubMed

Netherton, E.W. (1958). A unique case of trichorrexis invaginata. Arch. Dermatol. 78, 483–487.10.1001/archderm.1958.01560100059009Suche in Google Scholar PubMed

Prassas I., Eissa A., Poda G., and Diamandis, E.P. (2015). Unleashing the therapeutic potential of human kallikrein-related serine proteases. Nat. Rev. 14, 183–202.10.1038/nrd4534Suche in Google Scholar

Raghunath, M., Tontsidou, L., Oji, V., Aufenvenne, K., Schürmeyer-Horst, F., Jayakumar, A., Ständer, H., Smolle, J., Clayman, G.L., and Traupe, H. (2004). SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases. J. Invest. Dermatol. 3, 474–483.10.1111/j.0022-202X.2004.23220.xSuche in Google Scholar PubMed

Sales, K.U., Masedunskas, A., Bey, A.L., Rasmussen, A.L., Weigert, R., List, K., Szabo, R., Overbeek, P.A., and Bugge, T.H. (2010). Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome. Nat. Genet. 42, 676–683.10.1038/ng.629Suche in Google Scholar PubMed PubMed Central

Smith, D.L., Smith, J.G., Wong, S.W., and deShazo, R.D. (1995). Netherton’s syndrome. Br. J. Dermatol. 133, 153–154.10.1111/j.1365-2133.1995.tb02520.xSuche in Google Scholar PubMed

Sprecher, E., Amin, S., Nielsen, K., Pfendner, E., Uitto, J., Richard, G., Chavanas, S., DiGiovanna, J., Prendiville, J., Silverman, R., et al. (2001). The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. J. Invest. Dermatol. 2, 179–187.10.1046/j.1523-1747.2001.01389.xSuche in Google Scholar PubMed

Stefansson, K., Brattsand, M., Roosterman, D., Kempkes, C., Bocheva, G., Steinhoff, M., and Egelrud, T. (2008). Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases. J. Invest. Dermatol. 128, 18–25.10.1038/sj.jid.5700965Suche in Google Scholar PubMed

Stevanovic, D.V. (1969). Multiple defects of the hair shaft in Netherton’s disease. Association with ichthyosis linearis circumflexa. Br. J. Dermatol. 81, 851–857.10.1111/j.1365-2133.1969.tb15956.xSuche in Google Scholar PubMed

Traupe, H. (1989). The Ichthyosis: A Guide to Clinical Diagnosis, Genetic Counselling, and Therapy (Berlin Heidelberg: Springer-Verlag), pp. 45–78.10.1007/978-3-642-73650-6_5Suche in Google Scholar

Van Gysel, D., Koning, H., Baert, M.R.M., Savelkoul, H.F.J., Neijens, H.J., and Oranje, A.P. (2001).Clinico-immunological heterogeneity in Comel-Netherton syndrome. Dermatology 202, 99–107.10.1159/000051607Suche in Google Scholar PubMed

van Smeden, J., Janssens, M., Boiten, W.A., van Drongelen, V., Furio, L., Vreeken, R.J., Hovnanian, A., and Bouwstra, J.A. (2014). Intercellular skin barrier lipid composition and organization in Netherton syndrome patients. J. Invest. Dermatol. 5, 1238–1245.10.1038/jid.2013.517Suche in Google Scholar PubMed